Investigation of glycopeptide resistance in enterococcal strains isolated from Malatya, Kayseri and Elaziǧ Medical Faculty Hospitals;Malatya, Kayseri ve Elaziǧ tip fakültesi hastanelerinde izole edilen enterokok suşlarinda glikopeptid direncinin araştirilmasi

Mikrobiyoloji Bulteni

Volumn 35, Issue 2, 2001, Pages 197-209

  Ersoy, Y ^a   Sonmez E ^a   Young, H J ^a   Agel E ^a   Durmaz, B ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Enterococci; Genotypic analysis; Glycopeptide resistance

Indexed keywords

GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ARTICLE; DRUG SENSITIVITY; ENTEROCOCCUS; GENOTYPE; HOSPITAL INFECTION; HUMAN; INCIDENCE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 0034993224     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
2. Recovery of resistant enterococci during vancomycin prophylaxis
3. Vancomycin-resistant enterococci
4. Vancomycin-resistant Gram positive cocci: Risk factors for faecal carriage
5. Vancomycin-resistant Enterococcus faecium colonization in children
6. Vankomisine dirençli Enterococcus faecium suşu
7. Enterococci acquire new kinds of resistance
8. Enterococcus
9. Resistance to glycopeptides in enterococci
10. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
11. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states
12. Characterization of glycopeptide-resistant enterococci from U.S. hospitals
13. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR
14. Emergence of vancomycin-resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates
15. The 16S/23S ribosomal spacer region as a target for DNA probes to identify eubacteria
16. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms
17. Species identification of enterococci via intergenic ribosomal PCR
18. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin
19. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR
20. Focus on glycopeptides
21. Use of enzyme tests in characterization and identification of aerobic and facultatively anaerobic Gram positive cocci
22. E.faecium, not E.faecalis, is the culprit in vancomycin resistance
23. Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period
24. Evaluation of arbitrarily primed PCR analysis and pulsed-field gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine
25. Antimicrobial susceptibility testing of enterococci: Results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology
26. Quality assessment of glycopeptide susceptibility tests: A European collaborative study
27. Antimicrobial-resistant pathogens in the 1990s
28. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms
29. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms
30. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands
31. Management of infections due to resistant enterococci: A review of therapeutic options
32. Yenidoǧanlarda vankomisine dirençli enterokoklarin fekal taşiyiciliǧi
33. Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype)